Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P14
Within normal range
vs 2Y Ago
-1.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -55.95% |
| 2023 | 45.45% |
| 2022 | 49.17% |
| 2021 | -15.21% |
| 2020 | -36.27% |
| 2019 | -232.76% |
| 2018 | -1.75% |
| 2017 | 0.00% |